Japan’s MHLW Increases User Fee Rates, Earmarks Postmarket Device Staff
This article was originally published in The Gray Sheet
Executive Summary
The Pharmaceutical & Medical Device Organization in Japan plans to increase its device review staff from 19 employees to 38 by 2009
You may also be interested in...
No Fooling: Japanese User Fees, Revised Reimbursement Rates Debut April 1
New product applications should be assigned to one team of reviewers throughout the Japanese review process, according to AdvaMed
No Fooling: Japanese User Fees, Revised Reimbursement Rates Debut April 1
New product applications should be assigned to one team of reviewers throughout the Japanese review process, according to AdvaMed
Japan Home-Use Product Emphasis Displaces Long-Term Care, Physicians
The Ministry of Health, Labor & Welfare in Japan is displacing fees paid to long-term care (LTC) institutions in favor of the home-care sector, according to a Japanese health economist